CD8 T cells modulate CD4 T-cell and eosinophil-mediated pulmonary pathology in Pneumocystis pneumonia in B-cell-deficient mice

American Journal of Pathology

Volumn 168, Issue 2, 2006, Pages 466-475

  Swain, Steve D ^a   Meissner, Nicole N ^a   Harmsen, Allen G ^a  

^a MONTANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL POLARITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; EFFECTOR CELL; EOSINOPHILIA; HISTOPATHOLOGY; IMMUNE DEFICIENCY; MOUSE; NONHUMAN; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 33144463402     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2006.050724     Document Type: Article

References (54)

1. Sibille Y, Reynolds HY: Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am Rev Respir Dis 1990, 141:471-501
2. Lee NA, Gelfand EW, Lee JJ: Pulmonary T cells and eosinophils: coconspirators or independent triggers of allergic respiratory pathology? J Allergy Clin Immunol 2001, 107:945-957
3. Delclaux C, Azoulay E: Inflammatory response to infectious pulmonary injury. Eur Respir J Suppl 2003, 42:10s-14s
4. Hahn PY, Limper AH: The role of inflammation in respiratory impairment during Pneumocystis carinii pneumonia. Semin Respir Infect 2003, 18:40-47
5. Su TH, Martin II WJ: Pathogenesis and host response in Pneumocystis carinii pneumonia. Annu Rev Med 1994, 45:261-272
6. Walzer PD: Immunological features of Pneumocystis carinii infection in humans. Clin Diagn Lab Immunol 1999, 6:149-155
7. Harmsen AG, Stankiewicz M: Requirement for CD4+ cells in resistance to Pneumocystis carinii pneumonia in mice. J Exp Med 1990, 172:937-945
8. Chen W, Mills JW, Harmsen AG: Development and resolution of Pneumocystis carinii pneumonia in severe combined immunodeficient mice: a morphological study of host inflammatory responses. Int J Exp Pathol 1992, 73:709-720
9. Swain SD, Wright TW, Degel PM, Gigliotti F, Harmsen AG: Neither neutrophils nor reactive oxygen species contribute to tissue damage during Pneumocystis pneumonia in mice. Infect Immun 2004, 72:5722-5732
10. Wright TW, Gigliotti F, Finkelstein JN, McBride JT, An CL, Harmsen AG: Immune-mediated inflammation directly impairs pulmonary function, contributing to the pathogenesis of Pneumocystis carinii pneumonia. J Clin Invest 1999, 104:1307-1317
11. Wills-Karp M: Immunologic basis of antigen-induced airway hyperresponsiveness. Annu Rev Immunol 1999, 17:255-281
12. Dayer JM: How T-lymphocytes are activated and become activators by cell-cell interaction. Eur Respir J Suppl 2003, 44:10s-15s
13. Shelburne III SA, Hamill RJ: The immune reconstitution inflammatory syndrome. AIDS Rev 2003, 5:67-79
14. Wislez M, Bergot E, Antoine M, Parrot A, Carette MF, Mayaud C, Cadranel J: Acute respiratory failure following HAART introduction in patients treated for Pneumocystis carinii pneumonia. Am J Respir Crit Care Med 2001, 164:847-851
15. Marcotte H, Levesque D, Delanay K, Bourgeault A, de la Durantaye R, Brochu S, Lavoie MC: Pneumocystis carinii infection in transgenic B cell-deficient mice. J Infect Dis 1996, 173:1034-1037
16. Harmsen AG: Role of alveolar macrophages in lipopolysaccharide-induced neutrophil accumulation. Infect Immun 1988, 56:1858-1863
17. Duguet A, Iijima H, Eum SY, Hamid Q, Eidelman DH: Eosinophil peroxidase mediates protein nitration in allergic airway inflammation in mice. Am J Respir Crit Care Med 2001, 164:1119-1126
18. Wright TW, Pryhuber GS, Chess PR, Wang Z, Notier RH, Gigliotti F: TNF receptor signaling contributes to chemokine secretion, inflammation, and respiratory deficits during Pneumocystis pneumonia. J Immunol 2004, 172:2511-2521
19. Romagnani P, Annunziato F, Piccinni MP, Maggi E, Romagnani S: Th1/Th2 cells, their associated molecules and role in pathophysiology. Eur Cytokine Netw 2000, 11:510-511
20. Jarnicki AG, Fallon PG: T helper type-2 cytokine responses: potential therapeutic targets. Curr Opin Pharmacol 2003, 3:449-455
21. Kroegel C, Warner JA, Virchow Jr JC, Matthys H: Pulmonary immune cells in health and disease: the eosinophil leucocyte. Eur Respir J 1994, 7:743-760
22. Walsh GM: Eosinophil granule proteins and their role in disease. Curr Opin Hematol 2001, 8:28-33
23. Shinkai K, Mohrs M, Locksley RM: Helper T cells regulate type-2 innate immunity in vivo. Nature 2002, 420:825-829
24. Malm-Erjefalt M, Persson CG, Erjefalt JS: Degranulation status of airway tissue eosinophils in mouse models of allergic airway inflammation. Am J Respir Cell Mol Biol 2001, 24:352-359
25. Gonzalo JA, Lloyd CM, Kremer L, Finger E, Martinez AC, Siegelman MH, Cybulsky M, Gutierrez-Ramos JC: Eosinophil recruitment to the lung in a murine model of allergic inflammation. The role of T cells, chemokines, and adhesion receptors. J Clin Invest 1996, 98:2332-2345
26. Liu AN, Mohammed AZ, Rice WR, Fiedeldey DT, Liebermann JS, Whitsett JA, Braciale TJ, Enelow RI: Perforin-independent CD8(+) T-cell-mediated cytotoxicity of alveolar epithelial cells is preferentially mediated by tumor necrosis factor-alpha: relative insensitivity to Fas ligand. Am J Respir Cell Mol Biol 1999, 20:849-858
27. Huffnagle GB, Lipscomb MF, Lovchik JA, Hoag KA, Street NE: The role of CD4+ and CD8+ T cells in the protective inflammatory response to a pulmonary cryptococcal infection. J Leukoc Biol 1994, 55:35-42
28. Jones HP, Tabor L, Sun X, Woolard MD, Simecka JW: Depletion of CD8+ T cells exacerbates CD4+ Th cell-associated inflammatory lesions during murine mycoplasma respiratory disease. J Immunol 2002, 168:3493-3501
29. Adams B, Nagy N, Paulart F, Vanderhaeghen ML, Goldman M, Flamand V: CD8+ T lymphocytes regulating Th2 pathology escape neonatal tolerization. J Immunol 2003, 171:5071-5076
30. Hussell T, Baldwin CJ, O'Garra A, Openshaw PJ: CD8+ T cells control Th2-driven pathology during pulmonary respiratory syncytial virus infection. Eur J Immunol 1997, 27:3341-3349
31. Allakhverdi Z, Lamkhioued B, Olivenstein R, Hamid Q, Renzi PM: CD8 depletion-induced late airway response is characterized by eosinophilia, increased eotaxin, and decreased IFN-gamma expression in rats. Am J Respir Crit Care Med 2000, 162:1123-1131
32. Zimring JC, Kapp JA: Identification and characterization of CD8+ suppressor T cells. Immunol Res 2004, 29:303-312
33. Cortesini R, LeMaoult J, Ciubotariu R, Cortesini NS: CD8+CD28- T suppressor cells and the induction of antigen-specific, antigen-presenting cell-mediated suppression of Th reactivity. Immunol Rev 2001, 182:201-206
34. Chess L, Jiang H: Resurrecting CD8+ suppressor T cells. Nat Immunol 2004, 5:469-471
35. Molteni M, Rossetti C, Scrofani S, Bonara P, Scorza R, Kohn LD: Regulatory CD8+ T cells control thyrotropin receptor-specific CD4+ clones in healthy subjects. Cancer Detect Prev 2003, 27:167-174
36. Martin B, Banz A, Bienvenu B, Cordier C, Dautigny N, Becourt C, Lucas B: Suppression of CD4+ T lymphocyte effector functions by CD4+CD25+ cells in vivo. J Immunol 2004, 172:3391-3398
37. Belkaid Y, Rouse BT: Natural regulatory T cells in infectious disease. Nat Immunol 2005, 6:353-360
38. O'Garra A, Vieira P: Regulatory T cells and mechanisms of immune system control. Nat Med 2004, 10:801-805
39. Jaffar Z, Sivakuru T, Roberts K: CD4+CD25+ T cells regulate airway eosinophilic inflammation by modulating the Th2 cell phenotype. J Immunol 2004, 172:3842-3849
40. Hori S, Carvalho TL, Demengeot J: CD25+CD4+ regulatory T cells suppress CD4+ T cell-mediated pulmonary hyperinflammation driven by Pneumocystis carinii in immunodeficient mice. Eur J Immunol 2002, 32:1282-1291
41. Filaci G, Suciu-Foca N: CD8+ T suppressor cells are back to the game: are they players in autoimmunity? Autoimmun Rev 2002, 1:279-283
42. Humphreys IR, Edwards L, Walzl G, Rae AJ, Dougan G, Hill S, Hussell T: OX40 ligation on activated T cells enhances the control of Cryptococcus neoformans and reduces pulmonary eosinophilia. J Immunol 2003, 170:6125-6132
43. Iwamoto I, Nakajima H, Endo H, Yoshida S: Interferon gamma regulates antigen-induced eosinophil recruitment into the mouse airways by inhibiting the infiltration of CD4+ T cells. J Exp Med 1993, 177:573-576
44. Noble A, Zhao ZS, Cantor H: Suppression of immune responses by CDS cells. II. Qa-1 on activated B cells stimulates CD8 cell suppression of T helper 2 responses. J Immunol 1998, 160:566-571
45. Harris DP, Haynes L, Sayles PC, Duso DK, Eaton SM, Lepak NM, Johnson LL, Swain SL, Lund FE: Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat Immunol 2000, 1:475-482
46. Crow MK: Costimulatory molecules and T-cell-B-cell interactions. Rheum Dis Clin North Am 2004, 30:175-191, vii-viii
47. Lund FE, Garvy BA, Randall TD, Harris DP: Regulatory roles for cytokine-producing B cells in infection and autoimmune disease. Curr Dir Autoimmun 2005, 8:25-54
48. De Milito A: B lymphocyte dysfunctions in HIV infection. Curr HIV Res 2004, 2:11-21
49. Stoll M, Schmidt RE: Adverse events of desirable gain in immunocompetence: the immune restoration inflammatory syndromes. Autoimmun Rev 2004, 3:243-249
50. Koval CE, Gigliotti F, Nevins D, Demeter LM: Immune reconstitution syndrome after successful treatment of Pneumocystis carinii pneumonia in a man with human immunodeficiency virus type 1 infection. Clin Infect Dis 2002, 35:491-493
51. Barry SM, Lipman MC, Deery AR, Johnson MA, Janossy G: Immune reconstitution pneumonitis following Pneumocystis carinii pneumonia in HIV-infected subjects. HIV Med 2002, 3:207-211
52. Chen F, Sethi G, Goldin R, Wright AR, Lacey CJ: Concurrent granulomatous Pneumocystis carinii and Mycobacterium xenopi pneumonia: an unusual manifestation of HIV immune reconstitution disease. Thorax 2004, 59:997-999
53. Stone SF, Price P, Tay-Kearney ML, French MA: Cytomegalovirus (CMV) retinitis immune restoration disease occurs during highly active antiretroviral therapy-induced restoration of CMV-specific immune responses within a predominant Th2 cytokine environment. J Infect Dis 2002, 185:1813-1817
54. Stone SF, Price P, Keane NM, Murray RJ, French MA: Levels of IL-6 and soluble IL-6 receptor are increased in HIV patients with a history of immune restoration disease after HAART. HIV Med 2002, 3:21-27